COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Relay Therapeutics to Participate in Upcoming Investor Conferences21/05/2024
-   
  LifeStance Health Group Announces Launch of Secondary Public Offering21/05/2024
-   
  Trinity Biotech plc to Announce Q1 2024 Financial Results21/05/2024
-   
  Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares21/05/2024
-   
  Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)21/05/2024
-   
  Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update21/05/2024
-   
  Inventiva publie ses informations financières du 1 ͤ ͬ trimestre 2024¹ et fait un point sur ses activités21/05/2024
-   
  InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators21/05/2024
-   
  Smart for Life to Attend the 2024 NASC Annual Conference21/05/2024
-   
  ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication21/05/2024
-   
  Legend Senior Living Earns Great Place to Work® Certification for Sixth Time21/05/2024
-   
  Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders21/05/2024
-   
  BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders21/05/2024
-   
  Genmab Completes Acquisition of ProfoundBio21/05/2024
-   
  Mobile-health Network Solutions Revenue Rises Approximately 120% in the First Six Months of Fiscal 202421/05/2024
-   
  AssureCare Joins Forces with Health Plan Alliance to Enhance Healthcare Collaboration21/05/2024
-   
  Intrommune Therapeutics Presents Oral Mucosal Immunotherapy Updates at Leading Industry Events21/05/2024
-   
  Merit Medical Launches basixSKY™ Inflation Device21/05/2024
-   
  GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules21/05/2024
Pages